Cell Impact AB (CI) AI Stock Analysis

• Market Cap: kr50.14M
• Dividend Yield: N/A
• Average Volume (3M): 3.14M
• Price to Earnings (P/E): ―
• Beta (1Y): 1.90
• Revenue Growth: -70.31%
• EPS Growth: 52.58%
• Country: SE
• Employees: 41
• Sector: Industrials
• Sector Strength: 72
• Industry: Manufacturing - Metal Fabrication
• EPS (TTM): -0.30
• Shares Outstanding: 294,584,750
• 10 Day Avg. Volume: 5,393,382
• 30 Day Avg. Volume: 3,135,424
• PEG Ratio: N/A
• Price to Book (P/B): N/A
• Price to Sales (P/S): N/A
• P/FCF Ratio: N/A
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: Hold
• Number of Analyst Covering: 1

• Rating: 46 Neutral
• Price Target: kr0.00 ▼(-100.00% Downside)

The overall stock score is primarily impacted by the company's poor financial performance, characterized by declining revenues and profitability issues. Technical analysis provides some mixed signals but leans towards a bearish outlook. Valuation concerns, highlighted by a negative P/E ratio, further weigh down the score.

Cell Impact AB Business Overview & Revenue Model

Company Description

Cell Impact AB (publ) manufactures and sells bipolar flow plates for hydrogen fuel cells in Sweden and internationally. The company offers plates with and precise flow patterns. It serves hydrogen fuel cells producers. The company was incorporated in 1999 and is based in Karlskoga, Sweden.

How the Company Makes Money

Cell Impact AB makes money primarily through the sale of its highly specialized flow plates to manufacturers of fuel cells and electrolyzers. The company's revenue model is based on the production and sale of these components, which are critical for the function and efficiency of hydrogen-powered systems. Key revenue streams include direct sales to OEMs (Original Equipment Manufacturers) in the automotive and energy sectors, as well as strategic partnerships with companies involved in renewable energy projects. Additionally, Cell Impact may engage in collaborative development projects and licensing agreements to further monetize its proprietary manufacturing technologies and designs.

Cell Impact AB Financial Statement Overview

Summary

Cell Impact AB faces significant financial challenges, with declining revenues, negative profitability, and cash flow issues. The balance sheet remains relatively stable, but the company's operational inefficiencies and liquidity concerns pose substantial risks.

Income Statement

Cell Impact AB's income statement reveals significant challenges, with negative net profit margins and declining revenue. The TTM data shows a drastic revenue drop of 64.75%, and gross profit margins have deteriorated significantly. The company is struggling with profitability, as indicated by negative EBIT and EBITDA margins, reflecting operational inefficiencies and cost management issues.

Balance Sheet

The balance sheet shows moderate leverage with a debt-to-equity ratio of 0.14, indicating a conservative approach to debt. However, the return on equity is negative, reflecting the company's inability to generate returns for shareholders. The equity ratio remains stable, suggesting a solid capital structure, but the negative ROE highlights profitability concerns.

Cash Flow

Cash flow analysis indicates negative operating and free cash flows, with a declining trend in free cash flow growth. The operating cash flow to net income ratio is negative, suggesting cash flow issues. Despite a positive free cash flow to net income ratio, the overall cash flow position is weak, highlighting liquidity challenges.

Breakdown	TTM	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Income Statement
Total Revenue	11.79M	37.33M	47.26M	76.81M	71.35M	29.31M
Gross Profit	-3.23M	5.42M	25.45M	36.94M	34.88M	19.14M
EBITDA	-65.59M	-66.52M	-94.65M	-86.22M	-68.84M	-37.29M
Net Income	-99.46M	-100.43M	-121.40M	-104.22M	-79.85M	-44.26M
Balance Sheet
Total Assets	224.49M	261.25M	381.93M	401.51M	238.72M	242.88M
Cash, Cash Equivalents and Short-Term Investments	955.00K	20.39M	99.89M	164.67M	28.56M	151.93M
Total Debt	36.02M	30.92M	42.75M	44.70M	19.51M	21.98M
Total Liabilities	49.14M	42.16M	78.56M	77.17M	96.10M	40.99M
Stockholders Equity	175.34M	219.08M	303.37M	324.35M	142.63M	201.89M
Cash Flow
Free Cash Flow	-35.06M	-76.66M	-152.75M	-174.32M	-140.39M	-69.64M
Operating Cash Flow	-29.72M	-62.23M	-100.97M	-105.93M	-86.08M	-47.59M
Investing Cash Flow	-5.34M	-14.43M	-51.78M	-68.40M	-54.32M	-21.96M
Financing Cash Flow	13.39M	-2.84M	88.09M	310.47M	17.01M	204.57M

Cell Impact AB Technical Analysis

• Technical Analysis Sentiment: Positive
• Last Price: 0.17
• 50DMA: Positive
• 100DMA: Negative
• 200DMA: Negative
• MACD: Negative
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For SE:CI, the sentiment is Positive. The current price of 0.17 is above the 20-day moving average (MA) of 0.13, above the 50-day MA of 0.15, and below the 200-day MA of 0.42, indicating a neutral trend. The MACD of >-0.01 indicates Negative momentum. The RSI at 65.38 is Neutral, neither overbought nor oversold. The STOCH value of 58.67 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for SE:CI.

Cell Impact AB Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
Sector *	63 Neutral	$10.79B	15.43	7.44%	2.01%	2.89%	-14.66%
TRANS	54 Neutral	€511.12M	29.38	3.44%	―	8.67%	-49.01%
PCELL	51 Neutral	$1.75B	―	-1.36%	―	33.03%	87.01%
SALT.B	47 Neutral	€1.56B	―	-39.65%	―	-1.27%	-29.29%
CI	46 Neutral	kr50.14M	―	―	―	-70.31%	52.58%
AXOLOT	43 Neutral	kr122.71M	―	-31.89%	―	-34.39%	48.09%
BOMILL	36 Underperform	€88.07M	―	-76.10%	―	-34.86%	9.89%